Trial Information

Summary: A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Status: No longer recruiting

Protocol Number: WX17801

Sponsor: Hoffmann-La Roche; Aspreva Pharmaceuticals Corporation

Company Division: Pharmaceutical

Official Scientific Title: A randomized, double-blind study to evaluate the safety and efficacy of CellCept on treatment response and maintenance of remission in patients with lupus nephritis

Brief Summary: This 2 arm study will assess the efficacy of CellCept compared to cyclophosphamide in inducing a response in patients with lupus nephritis, and the long term efficacy of CellCept compared to azathioprine in maintaining remission and renal function. Patients will be randomized to receive either CellCept (1.5g bid) or cyclophosphamide (0.5-1.0g/m2 in monthly pulses) in the induction phase. Those patients meeting criteria for response will be re-randomized for entry into the maintenance phase, to receive either CellCept (1g bid) or azathioprine (2mg/kg/day). The anticipated time on study treatment is 2+ years, and the target sample size is 100-500 individuals. Target sample size is 358.

Study Phase: III

Study Design / Study Details:

• Purpose: Treatment
• Allocation: Randomized
• Masking: Double Blind
• Control: Active
• Assignment: Parallel
• Endpoints: Safety/Efficacy

Study Type:

Condition: Lupus Nephritis

Intervention Type: Drug

Intervention Name: mycophenolate mofetil [CellCept]

Primary Outcome: 1. Number of patients showing treatment response Time frame: 24 weeks 2. Time to treatment failure Time frame: 24-48 weeks

Key Secondary Outcomes: 1. Complete/partial remission, serum creatinine, urine protein, serum albumin, BILAG, SF36. Time frame: 24 weeks 2. Time to death, ESRD, doubling of serum creatinine, renal and extrarenal flare, rescue therapy. Time frame: 24-48 weeks

Inclusion Criteria:

Exclusion Criteria:

Gender: Males or Females

Age Limits: Min: 12 Years Max: 75 Years

Accepts Healthy Volunteers: No

Anticipated Start Date: July, 2005

Trial Registration Date: 09/18/2006

Date Last Updated: 06/17/2008

Link To Trial Results

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: July 14, 2008 at 1:06:47 PM